Cardiac sarcoidosis: worse pulmonary function due to left ventricular ejection fraction ? A case-control study.

M. Martusewicz-Boros (Warsaw, Poland), P. Boros (Warsaw, Poland), E. Wiatr (Warsaw, Poland), J. Zych (Warsaw, Poland), A. Kempisty (Warsaw, Poland), M. Kram (Warsaw, Poland), D. Piotrowska-Kownacka (Warsaw, Poland), S. Wesolowski (Warsaw, Poland), R. Baughman (Cincinnati, United States of America), K. Roszkowski-Sliz (Warsaw, Poland)

Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes
Session: Sarcoidosis: from basic research to patient outcomes
Session type: Poster Discussion
Number: 5216
Disease area: Interstitial lung diseases

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Martusewicz-Boros (Warsaw, Poland), P. Boros (Warsaw, Poland), E. Wiatr (Warsaw, Poland), J. Zych (Warsaw, Poland), A. Kempisty (Warsaw, Poland), M. Kram (Warsaw, Poland), D. Piotrowska-Kownacka (Warsaw, Poland), S. Wesolowski (Warsaw, Poland), R. Baughman (Cincinnati, United States of America), K. Roszkowski-Sliz (Warsaw, Poland). Cardiac sarcoidosis: worse pulmonary function due to left ventricular ejection fraction ? A case-control study.. 5216

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: